Inhibition of FOXP1 induces enhanced NPC cells proliferation and the expression of inflammatory factors (e.g., IL-1β, IL-6, and IL-8) leading to a sustained local inflammation. This evidence concerns the gene FOXP1 and nasopharyngeal carcinoma.